Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000767

Drug Information
NameDeforolimus    
SynonymsDeforolimus (USAN); AP-23573; D08900; AP 23573; Deforolimus; S1022_Selleck; Ridaforolimus; MK 8669; CID10191580; MK-8669; CID11520894; 42-(Dimethylphosphinate)rapamycin; 572924-54-0; AP23573, MK-8669, Ridaforolimus, Deforolimus    
CompanyAriad    
IndicationMultiple myelomaPhase II    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
CAS NumberCAS 572924-54-0
PubChem Compound IDCID 25199957.    
PubChem Substance IDSID 57376785.    
ClinicalTrials.govNCT00704054;    
TargetSerine/threonine-protein kinase mTORInhibitor[1]
Ref 1Emerging therapies for multiple myeloma. Expert Opin Emerg Drugs. 2009 Mar;14(1):99-127. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543